Market Research Store

Global C-Reactive Protein Testing Market 2017- Strategy Resources, Manufacturers to 2022

Global Market Research Report on C-Reactive Protein Testing Market 2017 is a professional and in-depth complete study on the current state of the C-Reactive Protein Testing worldwide.


Deerfield Beach, FL -- (SBWIRE) -- 06/26/2017 -- New report on C-Reactive Protein Tests are blood tests that measure the levels of C-Reactive Protein. C-reactive protein is a protein that is produced by the liver and its level increase when there is inflammation in the body. C-reactive tests identify and keep track of infections and diseases that cause inflammation such as certain types of cancers, cardiovascular diseases, arthritis, etc. According to the WHO, an estimated 17.3 million people died of cardiovascular diseases in 2008 alone. C-reactive protein tests estimate the risks of a person suffering from heart attacks or strokes. The main drivers for this market are the increasing incidences of cardiovascular diseases, and the sheer volume of tests required. Lack of public awareness would be a challenge to growth of this market. Opportunities for this market include the increasing applications for the test, applications in point of care testing, large target populations and higher global health care awareness, especially in developing countries.

Get Free Sample Report Of C-Reactive Protein Testing Market @

C-reactive protein tests are used in detection of inflammation seen in cases of infections after surgeries, diseases of immune system (Lupus), Rhematoid arthritis, cancers, inflammatory bowel disease and Cardiovascular diseases. The incidence of cardiovascular disease such as heart attacks and strokes is high and these tests are important to predict the occurrence of such diseases. The immunoassays used for C-reactive protein testing are ELISA, Immunoturbidimetric assays, Chemiluminesence immunoassay(CLIA)and High-sensitivity C-reactive protein (hsCRP) assay. The high-sensitivity C-reactive protein (hsCRP) assay is used as a marker for assessment of cardiac risks and as a prognostic tool for heart diseases. American Heart Association (AHA) and Centers for Disease Control and Prevention (CDC) recommends hsCRP as a more sensitive assay to predict vascular disease, as compared to the more traditional assays for circulating C-reactive protein levels. C-Reactive Protein Testing Market is segmented into North America, Europe, Asia-Pacific and RoW. Currently, the market is dominated by North America and Europe due to high prevalence of cardiovascular disease. However, Asia Pacific is an emerging market as the lifestyle related diseases such as cardiovascular diseases are on the rise.

Do Inquiry To Buy Report Of C-Reactive Protein Testing Market @

Market By Application

Cardiovascular diseases
Diseases of immune system
Rhematoid arthritis
Inflammatory bowel disease

Market By Type Of Assays

Chemiluminesence immunoassay(CLIA)
High-sensitivity C-reactive protein (hsCRP) assay

Market By Geography

North America